Cargando…
Adenoviral Vector Vaccines Antigen Transgene
In the past decade adenovirus-based vaccines have progressed from preclinical studies, which universally showed the vectors’ high immunogenicity, to testing in humans. Clinical trials showed that adenovirus vectors are well tolerated by humans. They induce robust immune responses that can be expande...
Autor principal: | Ertl, Hildegund C.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150117/ http://dx.doi.org/10.1016/B978-0-12-800276-6.00021-8 |
Ejemplares similares
-
Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004) -
COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021) -
Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
por: Takahashi, Marie-Noëlle, et al.
Publicado: (2010) -
Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
por: Afkhami, Sam, et al.
Publicado: (2023) -
Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)